Seattle Genetics is undoubtedly one of the notable Biotechnology companies in the United States. The biotech firm has been at the forefront in finding the solution to preventing and treating various types of cancer. The company has been undertaking research work, and it is currently making significant advancements in cancer therapy. Under his leadership, Seattle Genetics has experienced tremendous growth and is set to grow further as the teams in the firm undertake more research and come up with new ways of treating and preventing various types of cancer. Dr. Siegall has always been passionate about making the lives of cancer patients more bearable since he launched his career in biomedical studies.
Dr. Siegall currently serves as the president, CEO, and the chairman of the board of directors of Seattle Genetics. Dr. Siegall has served in this capacity since 2002. He has spent the last two decades growing Seattle Genetics to what it is today.
Dr. Siegall earned his Ph.D. in Genetics from George Washington University, and since then, he has amassed a lot of professional accomplishments. Siegall started his career as a Senior Research Investigator and was promoted to the position of Principal Scientist. He later moved to become a staff fellow and biotechnology Fellow at the National Cancer Institute.
One of the main reasons for Siegal’s professional’s accomplishments has been a commitment to focusing on the critical research and being diligent in implementing the most cutting-edge research developments. He has always been guided by a sincere desire to assist cancer patients, and he is very passionate to help alleviate their suffering. Dr. Siegall represents a rare combination of expertise and visionary leadership that is needed to steer scientific advancements to new heights.
Due to his exemplary performance in the industry, Siegall has won various coveted accolades including the Pacific Northwest Eranst and Young Entrepreneur of the year. Segall currently holds more than 15 patents and is always researching to find new breakthroughs in the medical field. Some of his major contributions include publishing widely on new research methods and new discoveries. As of now, he has published more than 70 scientific articles, and he continues to share his in-depth knowledge with other scientists and medical communities.